+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors



High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors



Digestive Endoscopy 22(1): 77




(PDF emailed within 0-6 h: $19.90)

Accession: 053538759

Download citation: RISBibTeXText

PMID: 20078674

DOI: 10.1111/j.1443-1661.2009.00923.x


Related references

The necessity of bone densitometry for patients taking selective serotonin reuptake inhibitors. Journal of Bone Metabolism 20(2): 95-98, 2014

The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper. Headache 50(6): 1089-1099, 2010

Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome. Endocrine 48(1): 65-68, 2015

Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study. Cns and Neurological Disorders Drug Targets 15(10): 1290-1298, 2016

Safety of methylene blue dye for lymphatic mapping in patients taking selective serotonin reuptake inhibitors. American Journal of Surgery 204(5): 798-799, 2013

Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. American Journal of Cardiology 98(1): 42-47, 2006

Prevalence of gastroduodenal mucosal injury in asymptomatic patients taking antiplatelet agents in Japan. International Journal of Clinical Pharmacology and Therapeutics 47(12): 722-725, 2010

Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. American Journal of Cardiology 114(4): 583-586, 2015

Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors. Journal of Affective Disorders 86(1): 99-104, 2005

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study. Bmc Research Notes 7: 459, 2015

Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort. Clinical Therapeutics 24(2): 237-248, February, 2002

Demographic, mental health, and offending characteristics of online child exploitation material offenders: A comparison with contact-only and dual sexual offenders. Behavioral Sciences and the Law 36(2): 198-215, 2018

Selective serotonin reuptake inhibitors for aggressive behavior in patients with dementia after head injury. PharmacoTherapy 21(4): 498-501, 2001

Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis. Journal of the American Geriatrics Society 63(5): 1002-1009, 2015

Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells. Biological and Pharmaceutical Bulletin 38(9): 1410-1414, 2016